Related Experiment Video

Updated: Aug 19, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Hypoglycemia in children with insulin-dependent diabetes mellitus

S Puczynski, M S Puczynski, C M Ryan

    The Diabetes Educator
    |March 1, 1992
    PubMed

    Insights

    Managing childhood diabetes aims to prevent complications and promote growth. Hypoglycemia acutely impacts cognitive functions like memory and learning, affecting school performance in children with insulin-dependent diabetes mellitus.

    Area of Science:

    • Pediatric Endocrinology
    • Neuroscience
    • Educational Psychology

    Background:

    • Normal growth and development, alongside preventing acute and long-term complications, are key management goals for children with insulin-dependent diabetes mellitus (IDDM).
    • Recent research offers new insights into the immediate effects of hypoglycemia on cognitive functions crucial for academic success.

    Purpose of the Study:

    • To review current understanding of hypoglycemia's acute cognitive effects in children with IDDM.
    • To discuss the impact of early-onset diabetes on academic performance.
    • To guide diabetes educators in integrating this knowledge into educational strategies.

    Main Methods:

    • Literature review of recent studies on hypoglycemia and cognitive function in pediatric diabetes.
    • Analysis of research on the relationship between early-onset diabetes and school performance.
    • Synthesis of findings for practical application in diabetes education.

    Main Results:

    • Hypoglycemia can acutely impair cognitive functions including learning, memory, reading, and visuospatial skills in children with IDDM.
    • Early-onset diabetes may have discernible effects on overall school performance.
    • This evidence underscores the need for targeted educational interventions.

    Conclusions:

    • Diabetes educators should incorporate findings on hypoglycemia's cognitive impact into educational plans for children with IDDM.
    • Families and schools play a vital role in supporting children with IDDM, requiring informed educational strategies.
    • Optimizing management and education can mitigate cognitive challenges and improve outcomes for children with diabetes.

    More Related Videos

    Improving IV Insulin Administration in a Community Hospital12:08

    Improving IV Insulin Administration in a Community Hospital

    Published on: June 11, 2012

    Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice07:35

    Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

    Published on: January 26, 2024

    Related Concept Videos

    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    Insulin: Dosing Regimen and Adverse Effects01:16

    Insulin: Dosing Regimen and Adverse Effects

    Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
    The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
    Hypoglycemia and Glucagon01:15

    Hypoglycemia and Glucagon

    Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
    Type I Diabetes III: Clinical Manifestations01:19

    Type I Diabetes III: Clinical Manifestations

    Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
    Hypoglycemia01:26

    Hypoglycemia

    Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...